BackMarinus Pharmaceuticals Overview

Marinus Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for MRNS.

Quarterly Cost of Revenue

$714000.00
↑ 56.92% YoY

As of Sep 30, 2024

Annual Cost of Revenue (TTM)

$3.49M
↑ 39.07% YoY

Trailing 12 months ending Sep 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin